Viewing Study NCT00130195


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2025-12-27 @ 9:11 PM
Study NCT ID: NCT00130195
Status: COMPLETED
Last Update Posted: 2008-11-14
First Post: 2005-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Sponsor: Japan Adult Leukemia Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module